Maze Therapeutics (MAZE) Shares Outstanding (2024 - 2026)
Maze Therapeutics (MAZE) posted Shares Outstanding (Entity) of $49.7 million for Q1 2026, up 0.81% sequentially from $49.3 million in Q4 2025, and up 73.74% YoY from $28.6 million in Q1 2025.
Maze Therapeutics (MAZE) Shares Outstanding (2024 - 2026) Analysis & Trends
Maze Therapeutics has reported Shares Outstanding (Entity) for 3 years, with the latest figure at $49.7 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 73.74% year-over-year to $49.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.7 million (up 73.74% YoY) and the FY2025 annual result came in at $49.3 million, up 1916.28% from the prior year.
- Shares Outstanding (Entity) grew to $49.7 million in Q1 2026 per MAZE's latest filing, from $49.3 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $49.7 million in Q1 2026 and troughed at $2.4 million in Q1 2024.
- A 3-year average of $25.5 million and a median of $28.6 million in 2025 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) soared 1916.28% in 2025, then jumped 73.74% in 2026.
- Over 3 years, Shares Outstanding (Entity) stood at $2.4 million in 2024, then jumped by 1916.28% to $49.3 million in 2025, then grew by 0.81% to $49.7 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $49.7 million, $49.3 million, and $48.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Maze Therapeutics | 1.51 Bn | 1.51 Bn | - | 59.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.00 Mn |
| Mar 31, 2026 | 53.90 Mn |
| Dec 31, 2025 | 42.98 Mn |
| Sep 30, 2025 | 45.78 Mn |
| Jun 30, 2025 | 43.80 Mn |
| Mar 31, 2025 | 28.63 Mn |
| Dec 31, 2024 | 2.40 Mn |
| Sep 30, 2024 | 2.42 Mn |
| Jun 30, 2024 | 2.39 Mn |
| Mar 31, 2024 | 2.34 Mn |